Clinical Research Directory

Inclusion Criteria: * Adult (age 18 and above) presenting with first suspected seizure(s). * Able to give informed consent. * Patient has received an initial epilepsy diagnosis. * Patient accepts decision to commence ASM. * Have an EEG prior to commencing ASMs. * Participants under watchful waiting who subsequently return to clinic for an epilepsy diagnosis (following a second seizure or a positive EEG) can be included in the study. They must have had an EEG performed in the 12 months prior to be being included in the study (to be used as a baseline EEG) and not have been taking any ASMs at the time. Exclusion Criteria: * Participants unable to tolerate an EEG test so no EEG data were gathered. * Participants with a known hepatic/renal encephalopathy. * Patient diagnosed with possible NEAD and epilepsy (dual diagnosis). * Participants taking part in another Clinical Trial of an Investigational Medicinal Product (CTIMP) (qualitative/observational studies are acceptable). * Patient receiving low does ASMs for other conditions (migraines etc).